African Stock Exchanges

NEIMETH - Neimeth International Pharma

Twitter · Facebook
NEIMETH share price on Nigerian Stock ExchangeNEIMETH share price on Nigerian Stock Exchange

Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.

NEIMETH1.90 ▪ 0.00
5 hours ago
Last Trading ResultsGrowth & Valuation
Opening Price:1.90Earnings Per Share:--
Day's Low Price:--Price/Earning Ratio:--
Day's High Price:--Dividend Per Share:--
Traded Volume:147,565Dividend Yield:--
Number of Deals:13Shares Outstanding:1.9b
Value/Turnover:265,664.50Market Capitalization:3.61b
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated

NEIMETH Stock Market Performance

1WK4WK3MO6MO1YRYTD
+0.00%-2.56%-11.63%-3.06%+216.67%-14.80%

The current share price of Neimeth International Pharma (NEIMETH) is NGN 1.90. The NEIMETH stock closed its last trading day (Wednesday, May 5, 2021) at 1.90 NGN per share on the Nigerian Stock Exchange. NEIMETH began the year with a share price of 2.23 NGN but has since lost 14.8% off that price valuation, ranking it 147th on the NSE in terms of year-to-date performance. The table below details the last 10 trading days of activity of Neimeth International Pharma on the Nigerian Stock Exchange.

DateVolumeCloseChangeChange%
2021-05-05147,5651.90----
2021-05-04550,8751.90+0.179.83%
2021-04-30260,8761.73----
2021-04-29109,5001.73----
2021-04-28659,0151.73-0.178.95%
2021-04-27141,5001.90----
2021-04-265,1101.90----
2021-04-23115,0001.90----
2021-04-2233,3811.90----
2021-04-2154,1771.90----

Profile of Neimeth International Pharmaceuticals Plc

Neimeth International Pharmaceuticals Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.

Factsheet of Neimeth International Pharmaceuticals Plc
Sector:
Health Care
Industry:
Pharmaceuticals & Biotechnology
Address:
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos, Nigeria
Telephone:
+234-903-254-3202, +234-815-949-1935
Email:
info@neimethplc.com.ng
Website:
www.neimethplc.com.ng

NEIMETH Industrial Market Competitors

Neimeth International Pharmaceuticals Plc, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have a number of market competitors who are also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below gives you an overview of the market standing of the top nine by year-to-date performance.

CodeNameMkt. Cap.L. PriceYearTD
MORISONMorison Industries929.81m0.94+91.8%
MAYBAKERMay & Baker Nigeria7.59b4.40+25.4%
FIDSONFidson Healthcare11.02b5.28+17.3%
NIG-GERMANNigeria-German Chemicals556.71m3.62+0.00%
EVANSMEDEvans Medical Plc366.17m0.50+0.00%
EKOCORPEkocorp Plc2.94b5.90-1.67%
GLAXOSMITHGlaxo Smithkline Consumer7.47b6.25-9.42%
UNIONDACUNIONDAC994.88m0.28-9.68%
PHARMDEKOPharma-Deko Plc290.54m1.34-10.7%

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. BRVM Stock Exchange
  3. Ghana Stock Exchange
  4. Johannesburg Stock Exchange
  5. Lusaka Stock Exchange
  6. Malawi Stock Exchange
  7. Nairobi Securities Exchange
  8. Nigerian Stock Exchange
  9. Uganda Securities Exchange
  10. Zimbabwe Stock Exchange

Comments (1)

  1. andrew sundayandrew sunday
    Apr 17, 2020 13:34 GMT

    Neimeth International Pharmaceuticals Plc recent address is Plot 16 Billings Way Oregun Industrial Estate, Oregun Lagos

  • Showing 1 - 1 of 1
NOTE: You are replying to 's comment. [Cancel]